{
    "organizations": [],
    "uuid": "917840d2f14a2629920f069546a1f20151f7cdb7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ab-biosciences-and-shire-enter-int/brief-ab-biosciences-and-shire-enter-into-agreement-idUSFWN1PP10X",
    "ord_in_thread": 0,
    "title": "BRIEF-AB Biosciences And Shire Enter Into Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Shire Plc:\n* AB BIOSCIENCES AND SHIRE ENTER INTO AGREEMENT FOR DEVELOPMENT AND COMMERCIALIZATION OF AB BIOSCIENCES’ PRIM PROGRAM\n* SHIRE PLC - NO FURTHER TERMS OF AGREEMENT WERE DISCLOSED * SHIRE PLC - ‍AB BIOSCIENCES TO RECEIVE AN UPFRONT LICENSE FEE AND POTENTIAL RESEARCH, DEVELOPMENT AND COMMERCIAL MILESTONE PAYMENTS FROM SHIRE​\n* SHIRE PLC - SHIRE RECEIVES EXCLUSIVE WORLDWIDE LICENSE TO DEVELOP AND COMMERCIALIZE PRIM PROGRAM Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-30T20:12:00.000+02:00",
    "crawled": "2018-01-31T16:09:39.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "shire",
        "plc",
        "ab",
        "bioscience",
        "shire",
        "enter",
        "agreement",
        "development",
        "commercialization",
        "ab",
        "bioscience",
        "prim",
        "program",
        "shire",
        "plc",
        "term",
        "agreement",
        "disclosed",
        "shire",
        "plc",
        "bioscience",
        "receive",
        "upfront",
        "license",
        "fee",
        "potential",
        "research",
        "development",
        "commercial",
        "milestone",
        "payment",
        "shire",
        "plc",
        "shire",
        "receives",
        "exclusive",
        "worldwide",
        "license",
        "develop",
        "commercialize",
        "prim",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}